Trending...
- Global Families Turn to Young Travelers Concierge Amid Rising Safety Concerns in the U.S
- Naperville: Inauguration of City Council Members Taking Place Sunday, May 4
- Six Elks Hoop Shoot Champions Enter Naismith Memorial Basketball Hall of Fame
NORTHFIELD, Ill., Sept. 17, 2024 ~ Dr. Brian McDonagh, MD, has been recognized as a Pinnacle Lifetime Member for his outstanding contributions to the medical field. The Inner Circle, a prestigious publication, prominently featured Dr. McDonagh for his exceptional work in the treatment of Multiple Sclerosis (MS), Crohn's disease, Migraine and Peripheral Neuropathy.
As the Founder of Vein Clinics of America (VCA), Dr. McDonagh is renowned worldwide for his discovery of the advanced ultrasound guided injection method for varicose veins. This groundbreaking technique has replaced traditional vein stripping surgery and has greatly improved the quality of life for many patients.
In addition to his pioneering work in vascular medicine, Dr. McDonagh is also recognized for his innovative neurological breakthroughs. His treatments have transformed the lives of patients suffering from MS, Crohn's disease, Migraine, Peripheral Neuropathy, and other conditions. These highly effective treatments have rapidly alleviated symptoms and improved overall patient outcomes.
More on illi News
A strong advocate for new medical ideas and innovations, Dr. McDonagh is honored to be acknowledged for his contributions to the fields of Neurology and Gastroenterology. He has made significant advancements in understanding Crohn's disease as an overactive neurogenic stimulus that can be easily treated within minutes. Currently, he is working on a promising treatment for blindness.
Dr. McDonagh's journey in medicine began at University College Dublin in Ireland where he earned his medical degree. He then completed an Internship at Tucson Hospital Medical Education Program followed by two years of Rehabilitation Medicine in Detroit before settling in Chicago where he practiced Primary Medical Care.
However, it was during this time that Dr. McDonagh developed painful varicose veins which led him to discover the micro-injection method for eliminating them. This discovery prompted him to found Vein Clinics of America (VCA), which now has 27 centers throughout the Eastern half of the USA.
Driven by a desire for new challenges, Dr. McDonagh became interested in Prolotherapy, a successful treatment for painful degenerative joint disease. He had both of his knees treated with this method in 2006 and has since been a strong advocate for its use as an alternative to joint replacement surgery.
More on illi News
Dr. McDonagh's interest in innovative treatments also led him to explore P.I.T. (perineural injection treatment), a new neurology developed by Dr. John Lyftogt in New Zealand. This treatment has shown quick and excellent results in sports injuries and Dr. McDonagh recommends it for Olympic athletes who want to return to their events as soon as possible after an injury.
Reflecting on his motivation to contribute to the field of medicine, Dr. McDonagh credits his wife and four children for their unwavering support throughout his career. His commitment to providing personalized and compassionate care to his patients has earned him recognition within the medical community.
Looking towards the future, Dr. McDonagh remains dedicated to delivering exceptional care and advancing medical knowledge. He is constantly seeking ways to improve treatments and patient outcomes. In his free time, he enjoys reading, music, opera, golf, tennis, and aviation (he has flown himself across the Atlantic several times). These diverse interests reflect his multifaceted approach to life.
For more information on Dr. Brian McDonagh's groundbreaking work in the medical field, please contact Katherine Green at 516-825-5634.
As the Founder of Vein Clinics of America (VCA), Dr. McDonagh is renowned worldwide for his discovery of the advanced ultrasound guided injection method for varicose veins. This groundbreaking technique has replaced traditional vein stripping surgery and has greatly improved the quality of life for many patients.
In addition to his pioneering work in vascular medicine, Dr. McDonagh is also recognized for his innovative neurological breakthroughs. His treatments have transformed the lives of patients suffering from MS, Crohn's disease, Migraine, Peripheral Neuropathy, and other conditions. These highly effective treatments have rapidly alleviated symptoms and improved overall patient outcomes.
More on illi News
- This Budget Didn't Break the System—It Exposed the Truth
- Statement From EWTN Chairman & CEO Michael P. Warsaw On The Election of Pope Leo XIV
- NBA Champion Lamar Odom Launches Anti-Addiction Meme Coin, Ushering in a Disruptive Innovation in Web3
- Mentor Agile Empowers Illinois Residents with Free Access To Product Management Training
- Midwest Pond Features & Landscapes Hits 100 Cleanouts This Spring, Expands Services Across Chicago
A strong advocate for new medical ideas and innovations, Dr. McDonagh is honored to be acknowledged for his contributions to the fields of Neurology and Gastroenterology. He has made significant advancements in understanding Crohn's disease as an overactive neurogenic stimulus that can be easily treated within minutes. Currently, he is working on a promising treatment for blindness.
Dr. McDonagh's journey in medicine began at University College Dublin in Ireland where he earned his medical degree. He then completed an Internship at Tucson Hospital Medical Education Program followed by two years of Rehabilitation Medicine in Detroit before settling in Chicago where he practiced Primary Medical Care.
However, it was during this time that Dr. McDonagh developed painful varicose veins which led him to discover the micro-injection method for eliminating them. This discovery prompted him to found Vein Clinics of America (VCA), which now has 27 centers throughout the Eastern half of the USA.
Driven by a desire for new challenges, Dr. McDonagh became interested in Prolotherapy, a successful treatment for painful degenerative joint disease. He had both of his knees treated with this method in 2006 and has since been a strong advocate for its use as an alternative to joint replacement surgery.
More on illi News
- Aureli Construction Sets the Standard for Seamless Home Additions in Greater Boston
- ScreenPoints Puts Film Investors in the Credits—and in the Money With New FinTech Platform
- Beyond Finance Wins Gold Stevie® Award for Customer Service Department of the Year in 23rd Annual American Business Awards
- Pathways to Adulthood Conference May 17 at Melville Marriott Honoring NYS Assembly Member Jodi Giglio, Suffolk County Legislator Nick Caracappa
- Adster Techologies awarded US Patent for breakthrough innovation in reducing latency in Ad Serving
Dr. McDonagh's interest in innovative treatments also led him to explore P.I.T. (perineural injection treatment), a new neurology developed by Dr. John Lyftogt in New Zealand. This treatment has shown quick and excellent results in sports injuries and Dr. McDonagh recommends it for Olympic athletes who want to return to their events as soon as possible after an injury.
Reflecting on his motivation to contribute to the field of medicine, Dr. McDonagh credits his wife and four children for their unwavering support throughout his career. His commitment to providing personalized and compassionate care to his patients has earned him recognition within the medical community.
Looking towards the future, Dr. McDonagh remains dedicated to delivering exceptional care and advancing medical knowledge. He is constantly seeking ways to improve treatments and patient outcomes. In his free time, he enjoys reading, music, opera, golf, tennis, and aviation (he has flown himself across the Atlantic several times). These diverse interests reflect his multifaceted approach to life.
For more information on Dr. Brian McDonagh's groundbreaking work in the medical field, please contact Katherine Green at 516-825-5634.
Filed Under: Business
0 Comments
Latest on illi News
- $56.7 Million Announced in Q1 2025 with Revenue Growth and Progress Toward NASDAQ Uplisting for AI Marketing Company: IQSTEL, Inc. Stock Symbol: IQSTD
- SAVVY MINING raised $500 million and launched BTC.XRP.DOGE cloud mining, increasing investors' returns by 30%
- New National Nonprofit Launches to Capture Firsthand Accounts of Adoption Stories
- The Tide Project Opens at Biennale Architettura 2025 in Venice Amplifying Youth Voices
- Wall Street analysts say BTC.XRP.DOGE cloud mining company SIX MINING is expected to achieve a 5-fold increase, allowing users to easily mine BTC
- Gen X Takes The Reins: New Book Guides Caregivers Juggling Parents, Kids, And Grandkids With Humor And Heart
- Naperville Welcomes Top Global Leaders Through Americas Competitiveness Exchange Visit
- Fray Fitness Launches Memorial Day Sale and Veteran Organization Giveaway
- ABM for Good™ Launches First Project with Build Change
- Local Nonprofit Files Lawsuit Against Trump Administration's Attack on AmeriCorps
- Pregis Honors Partners Driving Measurable Impact with Annual Pregis Purpose Awards
- ImagineX, in Collaboration with Qualys, Launches New mROC Services to Transform Enterprise Cyber Risk Management
- Ditch Micromanagement: New Leadership Book for Results-Driven, Accountability-Based Teams
- Jay Tapp was named Managing Director in British Columbia
- Hubei Heavy Equipment Makes a Striking Appearance at CIMT and Competes with International Brands
- 20 Patents Issued Worldwide, Cementing Company Leadership. First Ever Cable-Free 12-Lead ECG: HeartBeam, Inc. (Stock Symbol: BEAT)
- NASDAQ Uplisting for Higher Market Exposure and Wide Corporate Benefits to AI Boosted Marketing Company On Track Towards $1 Billion Revenue by 2027
- AAR announces investor conference schedule for May and June 2025
- Congressional Men's Health Caucus Shows Bipartisan Consensus and Focus on Prevention, Mental Health, and Closing the Lifespan Gap
- The Alternative AI Architecture That Creates Certainty and Trust - No More Guesses.